Lysando AG
PrivateLast Round
Strategic
Aug 2, 2021
Est. Valuation
$356.1M
Company Overview
Lysando AG operates in Healthcare & Life Sciences and is based in Triesenberg. Its latest recorded funding round was a Strategic round in August 2021.
Lysando AG is a biotechnology company that provides research and development services for antimicrobial proteins, called Artilysin®s, intended to combat pathogenic and antibiotic-resistant bacteria.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lysando AG Comparables
Compare Lysando AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Micreos Group | 76% | |
| GangaGen | 74% | |
| Telum Therapeutics | 73% |
For institutional investors. Book with your work email.
Lysando AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Aug 2, 2021 | ||||
| Corporate Funding | Nov 12, 2014 |
For institutional investors. Book with your work email.
Lysando AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lysando AG's valuation, stock price, and market status.
Is Lysando AG a public or private company?
Lysando AG is a private company.
What is the current stock price of Lysando AG?
Lysando AG is a private company, so its shares have no public market price. Caplight tracks Lysando AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lysando AG worth (valuation)?
Lysando AG's valuation is estimated at $356.1M based on funding round data.
Can I buy Lysando AG stock?
Lysando AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lysando AG's last funding round?
Lysando AG's most recent funding round was Strategic on August 2, 2021.
Who are the main investors in Lysando AG?
Investor information for Lysando AG is not publicly disclosed.
Will Lysando AG IPO soon?
No public IPO plans have been announced for Lysando AG.
How can I track Lysando AG secondary market activity?
Caplight tracks bids, offers, and trades in Lysando AG's shares on secondary markets.